Zobrazeno 1 - 10
of 231
pro vyhledávání: '"Rao, N.V.S."'
Autor:
De Jonghe, Sandra, Johnson, Mark D., Mamidi, Rao N.V.S., Vinken, Petra, Feyen, Bianca, Lammens, Godelieve, Proctor, Jim
Publikováno v:
In Chemico-Biological Interactions 1 November 2017 277:85-90
Autor:
Singh, Swapnil, Singh, Harshita, Tandon, Poonam, Chakraborty, Nirmalangshu, Rao, N.V.S., Ayala, A.P.
Publikováno v:
In Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 5 May 2017 178:142-150
Publikováno v:
In Vibrational Spectroscopy May 2017 90:38-45
Autor:
Singh, Swapnil, Singh, Harshita, Srivastava, Anubha, Tandon, Poonam, Deb, Rahul, Debnath, Somen, Rao, N.V.S., Ayala, A.P.
Publikováno v:
In Vibrational Spectroscopy September 2016 86:24-34
Autor:
Linda A. Snyder, Rajendra Damle, Shefali Patel, Jared Bohrer, Anna Fiorella, Jenny Driscoll, Rebecca Hawkins, Christopher F. Stratton, Carol D. Manning, Kanaka Tatikola, Volha Tryputsen, Kathryn Packman, Rao N.V.S. Mamidi
Publikováno v:
Molecular Cancer Therapeutics. 21:1115-1124
Patients with prostate cancer whose tumors bear deleterious mutations in DNA-repair pathways often respond to PARP inhibitors. Studies were conducted to compare the activity of several PARP inhibitors in vitro and their tissue exposure and in vivo ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db2a787c756c1f9a07c511a44ed0c647
https://doi.org/10.1158/1535-7163.mct-21-0798
https://doi.org/10.1158/1535-7163.mct-21-0798
Autor:
Rao N.V.S. Mamidi, Kathryn Packman, Volha Tryputsen, Kanaka Tatikola, Carol D. Manning, Christopher F. Stratton, Rebecca Hawkins, Jenny Driscoll, Anna Fiorella, Jared Bohrer, Shefali Patel, Rajendra Damle, Linda A. Snyder
Supplementary Figure from Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3208f82c3ebbd32b4702b7b9a8adf68b
https://doi.org/10.1158/1535-7163.22522747.v1
https://doi.org/10.1158/1535-7163.22522747.v1
Autor:
De Jonghe, Sandra, Proctor, Jim, Vinken, Petra, Feyen, Bianca, Wynant, Inneke, Marien, Dirk, Geys, Helena, Mamidi, Rao N.V.S., Johnson, Mark D.
Publikováno v:
In Chemico-Biological Interactions 5 December 2014 224:1-12
Autor:
Mamidi, Rao N.V.S., Proctor, Jim, De Jonghe, Sandra, Feyen, Bianca, Moesen, Esther, Vinken, Petra, Ma, Jing Ying, Bryant, Stewart, Snook, Sandra, Louden, Calvert, Lammens, Godelieve, Ways, Kirk, Kelley, Michael F., Johnson, Mark D.
Publikováno v:
In Chemico-Biological Interactions 25 September 2014 221:109-118
Autor:
Frank Jacobs, Loeckie de Zwart, I. Goris, Mario Monshouwer, Rao N.V.S. Mamidi, Lilian Y. Li, Italo Poggesi, Jan Snoeys, Peter Verboven, Ellen Scheers, Inneke Wynant
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 9, Pp 1107-1118 (2021)
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 9, Pp 1107-1118 (2021)
Erdafitinib is a potent oral pan‐fibroblast growth factor receptor inhibitor being developed as oncology drug for patients with alterations in the fibroblast growth factor receptor pathway. Erdafitinib binds preferentially to α1‐acid glycoprotei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3abbc9d1666772a5a4609f5ea1cec529
https://doi.org/10.1002/psp4.12682
https://doi.org/10.1002/psp4.12682
Autor:
Italo Poggesi, Hilde Bohets, Chi Keung, Inneke Wynant, Filip Cuyckens, Rao N.V.S. Mamidi, Ellen Scheers, Laurent Leclercq, Carine Borgmans
Publikováno v:
Xenobiotica. 51:177-193
This article describes in vivo biotransformation and disposition of erdafitinib following single oral dose of 3H-erdafitinib and 14C-erdafitinib to intact and bile duct-cannulated (BC) rats (4 mg/k...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67807dfe758efa22b6eb33a179cbfda4
https://doi.org/10.1080/00498254.2020.1821123
https://doi.org/10.1080/00498254.2020.1821123